NCT03678883 2026-04-039-ING-41 in Patients With Advanced CancersActuate Therapeutics Inc.Phase 2 Active not recruiting350 enrolled
NCT03449108 2025-11-21LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Cancer (TNBC), Anaplastic Thyroid Cancer, Osteosarcoma, or Other Bone and Soft Tissue SarcomasM.D. Anderson Cancer CenterPhase 2 Active not recruiting30 enrolled
NCT02880319 2025-09-09Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the BoneDana-Farber Cancer InstitutePhase 2 Active not recruiting150 enrolled 12 charts
NCT03709680 2025-01-14Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid TumorsPfizerPhase 2 Active not recruiting128 enrolled